# Microembolic Signals During CPVI (Circumferntial Pulmonary Vein Isolation) Assessed by TCD (Trans-cranial Doppler)

> **NCT02082366** · NA · COMPLETED · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Atrial Fibrillation.

## Interventions

- **DEVICE:** TCD monitoring of microembolic signal during procedure

## Key facts

- **NCT ID:** NCT02082366
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-01
- **Final completion:** 2015-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02082366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02082366, "Microembolic Signals During CPVI (Circumferntial Pulmonary Vein Isolation) Assessed by TCD (Trans-cranial Doppler)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02082366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*